This is a real world study of Depression among people who take Levoxyl, Moringa oleifera. The study is created by eHealthMe based on 13 reports from FDA and social media.
What are the drugs
Levoxyl (latest outcomes from 15,720 users) has active ingredients of levothyroxine sodium. It is often used in hypothyroidism.
Moringa oleifera (latest outcomes from 17 users) has active ingredients of drumstick tree.
On Mar, 10, 2015: 15 people reported to have side effects when taking Levoxyl, Moringa oleifera. Among them, 13 people (86.67%) have Depression.
Gender of people who have Depression when taking the drugs * :
Age of people who have Depression when taking the drugs * :
Severity of Depression when taking the drugs ** :
How people recovered from Depression ** :
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
More about the drug combination: Levoxyl, Moringa oleifera drug interactions
You can also:
NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.